BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15567919)

  • 1. Steroid-free lymphocyte depletion protocols. The potential for partial tolerance?
    McCauley J
    Contrib Nephrol; 2005; 146():43-53. PubMed ID: 15567919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation tolerance. A complex scenario awaiting clinical applicability.
    Sayegh MH; Perico N; Remuzzi G
    Contrib Nephrol; 2005; 146():95-104. PubMed ID: 15567924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte depletion as a barrier to immunological tolerance.
    Neujahr D; Turka LA
    Contrib Nephrol; 2005; 146():65-72. PubMed ID: 15567921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-free immunosuppression in organ transplantation.
    Luo G; Falta EM; Elster EA
    Curr Diab Rep; 2005 Aug; 5(4):305-10. PubMed ID: 16033684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid or calcineurin inhibitor-sparing immunosuppressive protocols.
    Grinyó JM; Cruzado JM
    Contrib Nephrol; 2005; 146():30-42. PubMed ID: 15567918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in immunosuppression for renal transplantation.
    Durrbach A; Francois H; Beaudreuil S; Jacquet A; Charpentier B
    Nat Rev Nephrol; 2010 Mar; 6(3):160-7. PubMed ID: 20125095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviewing the mechanism of peripheral tolerance in clinical transplantation.
    Suciu-Foca N; Cortesini R
    Contrib Nephrol; 2005; 146():132-142. PubMed ID: 15567927
    [No Abstract]   [Full Text] [Related]  

  • 9. T-cell depletion for transplant tolerance induction: promises and hurdles.
    Dumont FJ
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1275-8. PubMed ID: 14758765
    [No Abstract]   [Full Text] [Related]  

  • 10. Some observations on prope tolerance.
    Calne R; Watson CJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Prope" tolerance: induction, lymphocyte depletion with minimal maintenance.
    Calne R
    Transplantation; 2005 Jul; 80(1):6-7. PubMed ID: 16003225
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.
    Golshayan D; Pascual M
    Drugs; 2008; 68(15):2113-30. PubMed ID: 18840003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of immunosuppressive therapy in renal transplanted patients.
    Chiaramonte S; Dissegna D; Ronco C
    Contrib Nephrol; 2005; 146():73-86. PubMed ID: 15567922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting tolerance processes in transplantation.
    Waldmann H; Cobbold S
    Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.
    Kirk AD; Mannon RB; Kleiner DE; Swanson JS; Kampen RL; Cendales LK; Elster EA; Wakefield T; Chamberlain C; Hoffmann SC; Hale DA
    Transplantation; 2005 Oct; 80(8):1051-9. PubMed ID: 16278585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of immunosuppressive minimization and tolerance strategies.
    Brouard S; Budde K
    Transpl Int; 2015 Aug; 28(8):889-90. PubMed ID: 26178312
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological immunosuppressants: the way to clinical transplantation tolerance.
    Chatenoud L
    Transplant Proc; 1997; 29(1-2):51-5. PubMed ID: 9123108
    [No Abstract]   [Full Text] [Related]  

  • 19. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance induction by removal of alloreactive T cells: in-vivo and pruning strategies.
    Watson D; Hu M; Zhang GY; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Aug; 14(4):357-63. PubMed ID: 19610169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.